Abstract:The trial was conducted to study on the effects of different type of sodium butyrate on serum bio-chemical indices, antioxidant and anti-inflammatory function of broilers challenged with lipopolysaccharide ( LPS) . Feeding trial: a total of 1 000 one-day-old Lingnan yellow broilers were randomly allocated into 5 groups with 4 replicates in each group and 50 broilers per replicate. Broilers in control group were fed a basal diet, the others in experimental groups were fed the basal diets supplemented with 500 mg/kg powder sodium butyrate ( NaB) , and 250, 500 and 750 mg/kg coated sodium butyrate ( CNaB) , respectively. The LPS in-jection experiment was conducted followed a 50-day feeding trial, 72 fifty-day-old female broilers were select-ed randomly from control, NaB and 250 mg/kg CNaB group with the best growth performance, with 6 broilers per replicate. And they were allotted into a 2×3 factorial arrangement with challenge status (saline or LPS ex-posure) and feed diet (0, 500 mg/kg NaB or 250 mg/kg CNaB) as main factor for endotoxin exposure test. Half of broilers in each group were injected intraperitoneally with E.coli LPS (0.5 mg/kg body weight)at 53, 56 and 59 d of age, the remaining broilers were injected intraperitoneally with the same amount of saline as the LPS injected group. The trial lasted for 10 days. The results showed as follows: 1) compared with the saline injected group, the content of glucose and riglyceride in serum was significantly decreased in LPS injected group (P<0.05), but the serum uric acid content as significantly increased (P<0.05). The serum glucose content of NaB and CNaB groups injected with LPS was significantly higher than that of control group ( P<0.05) . 2) Compared with the saline injected group, the activity of superoxide dismutase ( SOD) and glutathi-one peroxidase ( GSH-Px) in serum and liver was significantly decreased in LPS injected group ( P<0. 05 or P<0.01) , the serum catalase ( CAT) activity was significantly decreased ( P<0.05) . The activity of SOD and CAT in serum and liver of NaB and CNaB groups injected with LPS was higher than that of control group ( P>0.05), but the malonaldehyde content was lower than that of control group (P>0.05). There were a signifi-cant interaction between dietary sodium butyrate and LPS injected on liver GSH-Px activity ( P<0.05) , and the two forms of sodium butyrate exerted an equal effect on antioxidant enzyme activity. 3) Compared with the sa-line injected group, the content of ceruloplasmin and interleukin-6 in serum at the age of 53 and 59 days was significantly increased in LPS injected group ( P<0.05) . The serum ceruloplasmin content at the age of 53 days of NaB and CNaB groups injected with LPS was significantly lower than that of control group (P<0.05). In conclusion, sodium butyrate can improve the nutrient metabolism, maintain antioxidant function and promote anti-inflammation function, the effects on anti-stress of 500 mg/kg NaB are equal to those of 250 mg/kg CNaB which contains 75 mg/kg effective substance.

Sodium butyrate attenuates soybean oil-based lipid emulsion-induced increase in intestinal permeability of lipopolysaccharide by modulation of P-glycoprotein in Caco-2 cells.

Soybean Oil-Based Lipid Emulsion Increases Intestinal Permeability of Lipopolysaccharide in Caco-2 Cells by Downregulation of P-Glycoprotein Via ERK-FOXO 3a Pathway

Sodium butyrate alleviates intestinal injury and microbial flora disturbance induced by lipopolysaccharides in rats

Lactobacillus fermentum ZYL0401 Attenuates Lipopolysaccharide-Induced Hepatic TNF-α Expression and Liver Injury via an IL-10- and PGE2-EP4-Dependent Mechanism.

Effects of Different Type of Sodium Butyrate on Serum Biochemical Indices, Antioxidant and Anti-Inflammatory Function of Broilers Challenged with Lipopolysaccharide

Sodium Butyrate Reduces Bovine Mammary Epithelial Cell Inflammatory Responses Induced by Exogenous Lipopolysaccharide, by Inactivating NF-κB Signaling

Sodium Butyrate Alleviates Lipopolysaccharide-Induced Inflammatory Responses by Down-Regulation of NF-κB, NLRP3 Signaling Pathway, and Activating Histone Acetylation in Bovine Macrophages

Sodium butyrate ameliorates sepsis-associated lung injury by enhancing gut and lung barrier function in combination with modulation of CD4+Foxp3+ regulatory T cells

Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate

Sodium butyrate protect bone mass in lipopolysaccharide-treated rats by reducing oxidative stress and inflammatory

Condensation of Soy Protein Peptides Contributes to Sequester Bile Acids and Mitigate LPS-Induced Inflammation

Sodium Butyrate Reduces High-Fat Diet-Induced Non-Alcoholic Steatohepatitis Through Upregulation of Hepatic GLP-1R Expression

Sodium caprylate improves intestinal mucosal barrier function and antioxidant capacity by altering gut microbial metabolism

Butyrate Mitigates Weanling Piglets From Lipopolysaccharide-Induced Colitis by Regulating Microbiota and Energy Metabolism of the Gut–Liver Axis

Sodium Butyrate Promotes Reassembly of Tight Junctions in Caco-2 Monolayers Involving Inhibition of MLCK/MLC2 Pathway and Phosphorylation of PKCβ2

Sodium Butyrate Ameliorates Oxidative Stress-Induced Intestinal Epithelium Barrier Injury and Mitochondrial Damage through AMPK-Mitophagy Pathway

Sodium butyrate protects against oxidative stress in HepG2 cells through modulating Nrf2 pathway and mitochondrial function

Butyrate Glycerides Protect against Intestinal Inflammation and Barrier Dysfunction in Mice

Sodium Butyrate Reduces Colitogenic Immunoglobulin A-Coated Bacteria and Modifies the Composition of Microbiota in IL-10 Deficient Mice

Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption

Butyrolactone-I from marine fungi alleviates intestinal barrier damage caused by DSS through regulating Lactobacillus johnsonii and its metabolites in the intestine of mice